Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Teva Pharma (TEVA) Completes Acquisition of 4.6% Mylan (MYL) Stake
June 19, 2015 8:35 AM EDTTeva Pharma (NYSE: TEVA) announced that it has completed the purchase of 4.61 percent of all outstanding shares of Mylan N.V. (Nasdaq: MYL), which will enable Teva to commence proceedings before the Dutch Enterprise Chamber, should it become... More
